Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling ...
15don MSN
3 Drug Stocks to Buy at a Discount
The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback